Bio-Rad Laboratories
BIO
$272.35
Share price
1.52%
Change (1 day)
-28.02%
Change (1 year)
Categories
Bio-Rad Laboratories, Inc. is an American manufacturer of products for the life science research and clinical diagnostics markets.
Revenue for Bio-Rad Laboratories (BIO)
Revenue in 2023 (TTM): $2.67 B
According to Bio-Rad Laboratories's latest financial reports the company's current revenue (TTM
) is $2.67 B.
In 2022 the company made a revenue of $2.80 B a decrease over the years 2021 revenue that were of $2.92 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Bio-Rad Laboratories from 2001 to 2023
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2023 (TTM) | $2.67 B | -4.67% |
| 2022 | $2.80 B | -4.12% |
| 2021 | $2.92 B | 14.81% |
| 2020 | $2.54 B | 10.12% |
| 2019 | $2.31 B | 0.97% |
| 2018 | $2.28 B | 6.03% |
| 2017 | $2.15 B | 4.41% |
| 2016 | $2.06 B | 2.41% |
| 2015 | $2.01 B | -7.15% |
| 2014 | $2.17 B | 1.99% |
| 2013 | $2.13 B | 3.07% |
| 2012 | $2.06 B | -0.21% |
| 2011 | $2.07 B | 7.6% |
| 2010 | $1.92 B | 8.01% |
| 2009 | $1.78 B | 1.13% |
| 2008 | $1.76 B | 20.76% |
| 2007 | $1.46 B | 14.69% |
| 2006 | $1.27 B | 7.87% |
| 2005 | $1.18 B | 8.35% |
| 2004 | $1.09 B | 9.74% |
| 2003 | $0.99 B | 11.27% |
| 2002 | $0.89 B | 9.2% |
| 2001 | $0.81 B |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $89.65 B | 3,256.43% | 🇺🇸 USA |
 Thermo Fisher Scientific TMO | $42.85 B | 1,504.37% | 🇺🇸 USA |
 Agilent Technologies A | $6.73 B | 152.13% | 🇺🇸 USA |
 Becton Dickinson BDX | $19.49 B | 629.69% | 🇺🇸 USA |
 General Electric GE | $69.52 B | 2,502.52% | 🇺🇸 USA |
 Danaher DHR | $22.51 B | 743.01% | 🇺🇸 USA |
 PerkinElmer
PKI | $3.35 B | 25.69% | 🇺🇸 USA |